Overview
- Mark Cuban said Cost Plus Drugs has given TrumpRx its API, allowing the portal to display Cost Plus prices and refer shoppers to buy there.
- TrumpRx will function as a search and referral website rather than a seller, with users directed to direct-to-consumer channels for out-of-pocket purchases.
- The initial scope remains limited, with reporting that Pfizer has agreed to participate and roughly 313 Pfizer medicines would be listed at launch.
- The Trump administration has also engaged GoodRx and pharmacy chains to support the platform, with the site planned to go live in early 2026.
- Cuban praised the effort as a good start but cautioned it will be superficial in impact, while promoting Cost Plus’s cost-plus 15% model that aims to lower prices as volume grows.